1 |
Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31.
DOI
ScienceOn
|
2 |
Wahl GM, Carr AM (2001). The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol, 3, 277-86.
DOI
ScienceOn
|
3 |
Warner M, Eskenazi B, Mocarelli P, et al (2002). Serum dioxin concentrations and breast cancer risk in the seveso women's health study. Environ Health Perspect, 110, 625-8.
|
4 |
Kang JS, Yoon YD, Cho IJ, et al (2005). Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock. J Pharmacol Exp Ther, 312, 1187-94.
|
5 |
Kerdivel G, Habauzit D, Pakdel F (2013). Assessment and molecular actions of endocrine-disrupting chemicals that interfere with estrogen receptor pathways. Int J Endocrinol, 2013, 501851.
|
6 |
Mimuraa J, Fujii-Kuriyama Y (2003). Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta, 1619, 263-8.
DOI
ScienceOn
|
7 |
Polyak K, Lee MH, Erdjument-Bromage H, et al (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
DOI
ScienceOn
|
8 |
Read AP, Strachan T (1999). Human molecular genetics 2. New York: Wiley; ISBN 0-471-33061-2. Chapter 18: cancer Genetics.
|
9 |
Ryan KM, Phillips AC, Vousden KH (2001). Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol, 13, 332-7.
DOI
ScienceOn
|
10 |
Shanle EK, Xu W (2011). Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action. Chem Res Toxicol, 24, 6-19.
DOI
ScienceOn
|
11 |
Craig WJ (1999). Health-promoting properties of common herbs. Am J Clin Nutr, 70, 491-9.
DOI
|
12 |
Cheel J, Antwerpen PV, Tumova L, et al (2010). Free radicalscavenging, antioxidant and immunostimulating effects of a licorice infusion (Glycyrrhiza glabra L). Food Chemistry, 122, 508-17.
DOI
ScienceOn
|
13 |
Chen JX, Cheng MC, Li Y, Jiang CB (2011). Relationship between CYP1A1 genetic polymorphisms and renal cancer in China. Asian Pac J Cancer Prev, 12, 2163-6.
|
14 |
Chen YJ, Hung CM, Kay N, et al (2012). Progesterone receptor is involved in 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-stimulated breast cancer cells proliferation. Cancer Letter, 319, 223-31.
DOI
ScienceOn
|
15 |
Cravedi JP, Zalko D, Savouret JF, et al (2007). The concept of endocrine disruption and human health. Med Sci, 23, 198-204.
|
16 |
Fukai T, Satoh K, Nomura T, Sakagami H (2003). Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra. Fitoterapia, 74, 624-9.
DOI
ScienceOn
|
17 |
Giordano A, Normanno N (2009). Breast cancer in the postgenomic era. Brit J Cancer, 103, 155.
|
18 |
Jablonska O, Piasecka J, Petroff BK, et al (2011). In vitro effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) on ovarian, pituitary and pineal function in pigs. Theriogenology, 76, 921-32.
DOI
ScienceOn
|
19 |
Hrabia A, Lesniak A, Sechman A (2013). In vitro effects of TCDD, PCB126 and PCB153 on estrogen receptors, caspases and metalloproteinase-2 mRNA expression in the chicken shell gland. Folia Biologica, 61, 277-82.
DOI
|
20 |
Hu X, Moscinski LC (2011). CDC2: a monopotent or pluripotent CDK? Cell Prolif, 44, 205-11.
DOI
ScienceOn
|
21 |
Abdel-Rahim M, Smith R, Safe S (2003). Aryl hydrocarbon receptor gene silencing with small inhibitory rna differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol, 63, 1373-81.
DOI
ScienceOn
|
22 |
Abdel-Rahman WM, Moustafa YM, Ahmed BO, Mostafa RM (2012). Endocrine disruptors and breast cancer risk - time to consider the environment. Asian Pac J Cancer Prev, 13, 5937-46.
과학기술학회마을
DOI
ScienceOn
|
23 |
Androutsopoulos VP, Tsatsakis AM, Spandidos DA (2009). Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer, 9, 187.
DOI
ScienceOn
|
24 |
Bidgoli SA, Khorasani H, Keihan H, Sadeghipour A, Mehdizadeh A (2012). Role of endocrine disrupting chemicals in the occurrence of benign uterine leiomyomata: special emphasis on AhR tissue levels. Asian Pac J Cancer Prev, 11, 5445-50.
과학기술학회마을
DOI
ScienceOn
|
25 |
Bidgoli SA, Korani M, Bozorgi N, et al (2011). Association between glycodelin and aryl hydrocarbon receptor in Iranian breast cancer patients: impact of environmental endocrine disrupting chemicals. Asian Pac J Cancer Prev, 12, 2431-5.
|
26 |
Beischlag TV, Morales JL, Hollingshead BD, Perdew GH (2008). The aryl hydrocarbon receptor complex and the control of gene expression. Toxicology, 268, 132-8.
|
27 |
Casalini P, Iorio MV, Berno V, et al (2007). Relationship between p53 and p27 expression following HER2 signaling. The Breast, 16, 597-605.
DOI
ScienceOn
|
28 |
Pelekanou V, Leclercq G (2011). Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis. Int J Dev Biol, 55, 869-78.
DOI
ScienceOn
|
29 |
Kamei J, Nakamura R, Ichiki H, Kubo M (2003). Anti-tussive principles of glycyrrhiza radix, a main component of the kampo preparations bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol, 469, 159-63.
DOI
ScienceOn
|